Early research (Phase 1)Study completedNCT00003548What this trial is testingAminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal CavityWho this might be right forCancer NYU Langone Health 20
Early research (Phase 1)Study completedNCT00654160What this trial is testingIrinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal CancerWho this might be right forAnal CancerCarcinoma of the AppendixColorectal Cancer+9 more Mayo Clinic 7
Early research (Phase 1)Looking for participantsNCT07594964What this trial is testingTo Evaluate the Safety, Tolerability, and Preliminary Efficacy of XH001 Injection as Adjuvant Therapy in Patients With High-risk Recurrent Solid TumorsWho this might be right forBiliary Cancer (Cholangiocarcinoma, Gall Bladder Cancer)Pancreatic Ductal Adenocarcinoma (PDAC)Hepatocellular Carcinoma (HCC)+1 more Shenzhen Xinhe Biomedical 48
Early research (Phase 1)Study completedNCT00101972What this trial is testingRAV12 in Treating Patients With Metastatic or Recurrent AdenocarcinomaWho this might be right forCancer MacroGenics 53
Testing effectiveness (Phase 2)Study completedNCT04426669What this trial is testingMetastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic EngineeringWho this might be right forGastrointestinal Epithelial CancerGastrointestinal NeoplasmsCancer of Gastrointestinal Tract+8 more Intima Bioscience, Inc. 23
Early research (Phase 1)Study completedNCT00003439What this trial is testingInterleukin-12 in Treating Patients With Refractory Advanced-Stage Ovarian Cancer or Abdominal CancerWho this might be right forCancer National Cancer Institute (NCI) 36
Early research (Phase 1)Study completedNCT00003867What this trial is testingIrinotecan and Capecitabine in Treating Patients With Solid TumorsWho this might be right forCancer Montefiore Medical Center 30
Early research (Phase 1)Study completedNCT00003427What this trial is testingOxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal CancerWho this might be right forAnal CancerColorectal CancerEsophageal Cancer+7 more Memorial Sloan Kettering Cancer Center 36
Testing effectiveness (Phase 2)Active Not RecruitingNCT04068194What this trial is testingTesting the Combination of New Anti-cancer Drug Peposertib With Avelumab and Radiation Therapy for Advanced/Metastatic Solid Tumors and Hepatobiliary MalignanciesWho this might be right forLocally Advanced Malignant Solid NeoplasmLocally Advanced Unresectable CholangiocarcinomaLocally Advanced Unresectable Gallbladder Carcinoma+7 more National Cancer Institute (NCI) 103
Early research (Phase 1)Study completedNCT00486356What this trial is testingCapecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic CancerWho this might be right forExtrahepatic Bile Duct CancerGallbladder CancerGastric Cancer+2 more University of Nebraska 46
Early research (Phase 1)Study completedNCT00055705What this trial is testingPV701 in Treating Patients With Advanced or Recurrent Peritoneal CancerWho this might be right forCancer Memorial Sloan Kettering Cancer Center
Not applicableStudy completedNCT00489515What this trial is testingVisceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or GallbladderWho this might be right forColorectal CancerGallbladder CancerGastric Cancer+2 more Wake Forest University Health Sciences 115
Not applicableStudy completedNCT02430662What this trial is testingIrreversible Electroporation(IRE) For Unresectable Gallbladder NeoplasmsWho this might be right forGallbladder Neoplasms Fuda Cancer Hospital, Guangzhou 30
Large-scale testing (Phase 3)Study completedNCT00016380What this trial is testingOndansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper AbdomenWho this might be right forCancer NCIC Clinical Trials Group 211
Testing effectiveness (Phase 2)Ended earlyNCT00955721What this trial is testingCombination of Gemcitabine, Oxaliplatin (GEMOX)-Sorafenib in Patients With Advanced Biliary Tract CancerWho this might be right forCholangiocarcinomaBiliary Tract CancerGallbladder Cancer University of Miami 9
Early research (Phase 1)Study completedNCT00049296What this trial is testingThalidomide and Docetaxel in Treating Patients With Advanced CancerWho this might be right forCancer Case Comprehensive Cancer Center 26
Early research (Phase 1)Study completedNCT00066404What this trial is testingIntrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural EffusionsWho this might be right forCancer Abramson Cancer Center at Penn Medicine
Early research (Phase 1)Study completedNCT00019513What this trial is testingCombination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or LymphomasWho this might be right forColorectal CancerEsophageal CancerExtrahepatic Bile Duct Cancer+7 more National Institutes of Health Clinical Center (CC) 108
Early research (Phase 1)Study completedNCT01825603What this trial is testingADH-1, Gemcitabine Hydrochloride & Cisplatin in Treating Metastatic Pancreatic or Biliary Tract CancerWho this might be right forAmpulla of Vater AdenocarcinomaGallbladder AdenocarcinomaMetastatic Pancreatic Adenocarcinoma+17 more University of Nebraska 17
Early research (Phase 1)Study completedNCT00266097What this trial is testingOxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract CancerWho this might be right forExtrahepatic Bile Duct CancerGallbladder CancerPancreatic Cancer UNC Lineberger Comprehensive Cancer Center 23